Science
Mechanism of Action
Derived from the gene coding for Basic Fibroblast Growth Factor (bFGF or FGF-2), RH-POLYPEPTIDE-1 operates by directly stimulating the growth and proliferation of dermal fibroblasts. This action significantly boosts the synthesis of collagen and other extracellular matrix components, which are crucial for maintaining skin structure and reducing the appearance of wrinkles. Furthermore, it plays a role in regulating blood vessel development to enhance nutrient delivery to epidermal cells, supporting their growth and differentiation. The peptide also interacts synergistically with Epidermal Growth Factor (EGF) and Insulin-like Growth Factor-1 (IGF-1), amplifying the skin's natural production of hyaluronic acid for a smoother, healthier complexion. Its potential for melanocyte migration and re-pigmentation also suggests broader regenerative capabilities.
Research
Clinical Evidence
Medium confidence5%
Transparency
Dusting Analysis
There is insufficient data available to determine if RH-POLYPEPTIDE-1 is commonly 'dusted' or to establish specific dusting thresholds in cosmetic formulations.
The Formula
Formulation
Stability
As a peptide, RH-POLYPEPTIDE-1 exhibits pH-dependent stability and solubility. Deamidation rates are known to increase under alkaline conditions, and oxidation accelerates when the pH exceeds 7. For optimal formulation, meticulous reconstitution from lyophilized powder is essential to ensure complete dissolution without aggregation or degradation. Given its relatively large molecular size, effective topical application and enhanced stability often require encapsulation within advanced delivery systems, such as liposomes or PLGA-coated nanoparticles.
Synergies
- Hyaluronic Acid (boosted production, often co-formulated)
- Carboxymethyl Cellulose (co-formulated in clinical study)
- Epidermal Growth Factor (EGF) (interacts to boost HA production)
- Insulin-like Growth Factor-1 (IGF-1) (interacts to boost HA production)
Safety
Safety Profile
While safety and toxicity studies for topical SH-Polypeptide-1 (a synonym for RH-POLYPEPTIDE-1) have indicated low irritation and no significant adverse effects, its regulatory status presents a critical consideration. RH-POLYPEPTIDE-1 is listed in CosIng under Annex II/416 of the EU Cosmetics Regulation, which prohibits 'Cells, tissues or products of human origin' in cosmetic products. Consequently, EWG Skin Deep rates 'Rh Polypeptide 1' as 'Unacceptable' for EWG VERIFIED products. Although personal concerns such as cancer, allergies, and developmental toxicity are rated 'LOW', its classification as a product of human origin poses a substantial regulatory impediment for cosmetic product development in key markets.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite demonstrating promising in-vitro efficacy for skin rejuvenation and exhibiting low topical irritation, RH-POLYPEPTIDE-1's explicit prohibition under EU cosmetics regulations due to its human origin classification renders it unsuitable for compliant product development in many global markets.
Related
Similar Ingredients
Finding similar ingredients…